The carcinogenicity of opium consumption: a systematic review and meta-analysis.
Cancer
Case–control study
Cohort study
Meta-analysis
Opium
Journal
European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
16
07
2022
accepted:
15
01
2023
medline:
11
4
2023
pubmed:
12
2
2023
entrez:
11
2
2023
Statut:
ppublish
Résumé
The carcinogenicity of opium consumption was recently evaluated by a Working Group convened by the International Agency for Research on Cancer (IARC). We supplement the recent IARC evaluation by conducting an extended systematic review as well as a quantitative meta-analytic assessment of the role of opium consumption and risk for selected cancers, evaluating in detail various aspects of study quality on meta-analytic findings. We searched the published literature to identify all relevant studies on opium consumption and risk of selected cancers in humans through 31 October, 2022. Meta-relative risks (mRRs) and associated 95% confidence intervals (CIs) were estimated using random-effects models for studies of cancer of the urinary bladder, larynx, lung, oesophagus, pancreas, and stomach. Heterogeneity among studies was assessed using the I
Identifiants
pubmed: 36773182
doi: 10.1007/s10654-023-00969-7
pii: 10.1007/s10654-023-00969-7
pmc: PMC10082119
doi:
Substances chimiques
Opium
8008-60-4
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
373-389Subventions
Organisme : NCI NIH HHS
ID : R01 CA033193
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA033193
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. The Author(s).
Références
World Drug Report (United Nations publication, Sales No. E.21.XI.8). GLOBAL OVERVIEW: DRUG DEMAND DRUG SUPPLY [Internet]. 2021. Available from: https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_2.pdf
IARC. Opium consumption. IARC monogr identif carcinog hazards hum. 2021;126:1–253 (Internet).
Etemadi A, Hariri S, Hassanian-moghaddam H, Poustchi H, Roshandel G, Shayanrad A, et al. Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan cohort study. Int J Drug Policy. 2022;104:103695.
pubmed: 35472727
doi: 10.1016/j.drugpo.2022.103695
Friesen M, O’Neill IK, Malaveille C, Garren L, Hautefeuille A, Cabral JRP, et al. Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophagel cancer in Iran. Mutat Res Mol Mech Mutagen. 1985;150(1–2):177–91.
doi: 10.1016/0027-5107(85)90114-9
MacLennan R, da Costa J, Day NE, Law CH, Ng YK, Shanmugaratnam K. Risk factors for lung cancer in singapore chinese, a population with high female incidence rates. Int J Cancer. 1977;20(6):854–60.
pubmed: 591126
doi: 10.1002/ijc.2910200606
Khoo R. Radiotherapy of carcinoma of the Larynx. Ann Acad Med Singapore. 1981;10(3):307–10.
pubmed: 7332300
Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer. 2008;98(11):1857–63.
pubmed: 18475303
pmcid: 2410115
doi: 10.1038/sj.bjc.6604369
Sheikh M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, et al. Opium use and subsequent incidence of cancer: results from the Golestan cohort study. Lancet Glob Health. 2020;8(5):e649–60.
pubmed: 32353313
pmcid: 7196888
doi: 10.1016/S2214-109X(20)30059-0
IARC monographs on the evaluation of carcinogenic risks to humans. Report of the IARC advisory group to recommend on quantitative risk characterization Lyon, France: 18–19 November 2013 [Internet]. Available from: https://monographs.iarc.who.int/wp-content/uploads/2018/06/14-001.pdf
Afshari M, Janbabaei G, Bahrami MA, Moosazadeh M. Opium and bladder cancer: a systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer. PLoS ONE. 2017;12(6):e0178527.
pubmed: 28586371
pmcid: 5460843
doi: 10.1371/journal.pone.0178527
Bidary MZ, Sahranavard M, Rezayat AA, Omranzadeh A, Hoseiny SH, Kabirian A, et al. Opium as a carcinogen: a systematic review and meta-analysis. EClinicalMedicine. 2021;33:100768.
pubmed: 33718852
pmcid: 7921501
doi: 10.1016/j.eclinm.2021.100768
Singh G, Jaiswal A, Goel A, Raghav P. Opium usage and risk of head and neck cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2021;22(3):661–70.
pubmed: 33773527
pmcid: 8286690
doi: 10.31557/APJCP.2021.22.3.661
Kamangar F, Shakeri R, Malekzadeh R, Islami F. Opium use: an emerging risk factor for cancer? Lancet Oncol. 2014;15(2):e69-77.
pubmed: 24480557
doi: 10.1016/S1470-2045(13)70550-3
Mansouri M, Naghshi S, Parsaeian M, Sepanlou SG, Poustchi H, Sanat ZM, et al. Opium use and cancer risk: a comprehensive systematic review and meta-analysis of observational studies. Int J Clin Pract. 2022;2022:1–12.
doi: 10.1155/2022/5397449
HAWC: Health assessment workplace collaborative [Computer software]. 2013 [Internet]. Available from: https://hawcproject.org
Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, et al. Opium use and risk of pancreatic cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2018;27(3):268–73.
pubmed: 29263189
doi: 10.1158/1055-9965.EPI-17-0592
Bakhshaee M, Raziee HR, Afshari R, Amali A, Roopoosh M, Lotfizadeh A. Opium addiction and risk of laryngeal and esophageal carcinoma. Iran J Otorhinolaryngol. 2017;29(90):19–22.
pubmed: 28229058
pmcid: 5307300
Aliasgari MA, Kaviani A, Gachkar L, Hosseini-Nassab SR. Is bladder cancer more common among opium addicts? Urol J. 2004;1(4):253–5.
pubmed: 17914701
Aliramaji A, Kaseean A, Yousefnia Pasha YR, Shafi H, Kamali S, Safari M, et al. Age distribution types of bladder cancers and their relationship with opium consumption and smoking. Casp J Intern Med. 2015;6(2):82–6.
Hakami R, Etemadi A, Kamangar F, Pourshams A, Mohtadinia J, Firoozi MS, et al. Cooking methods and esophageal squamous cell carcinoma in high-risk areas of Iran. Nutr Cancer. 2014;66(3):500–5.
pubmed: 24033341
doi: 10.1080/01635581.2013.779384
Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Parsaeian M, Babaei M, et al. Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions. Int J Cancer. 2014;134(1):181–8.
pubmed: 23797606
doi: 10.1002/ijc.28344
Sadeghi A, Behmard S, Vesselinovitch SD. Opium: a potential urinary bladder carcinogen in man. Cancer. 1979;43(6):2315–21.
pubmed: 455221
doi: 10.1002/1097-0142(197906)43:6<2315::AID-CNCR2820430622>3.0.CO;2-J
Pournaghi SJ, Hojjat SK, Barazandeh Noveyri F, Tavakkoli Ghouchani H, Ahmadi A, Hamedi A, et al. Tobacco consumption, opium use, alcohol drinking and the risk of esophageal cancer in North Khorasan. Iran J Subst Use. 2019;24(1):105–9.
doi: 10.1080/14659891.2018.1523962
Nourbakhsh A, Mohseni MG, Hatmi ZN. Opium use in transitional cell carcinoma of the urinary bladder. Acta Med Iran. 2006;44(4):263–7.
Toutounchi M, Mazdak H, Najafipour S, Soleymani B. Bladder cancer risk factors among Isfahan population: a case-control study. J Res Med Sci. 2000;5(2):151–6.
Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008.
IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14(1):25.
pubmed: 24548571
pmcid: 4015721
doi: 10.1186/1471-2288-14-25
Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med. 2003;22(17):2693–710.
pubmed: 12939780
doi: 10.1002/sim.1482
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
pubmed: 12111919
doi: 10.1002/sim.1186
Abdolahinia Z, Pakmanesh H, Mirzaee M, Bazrafshan A, Shafiei Bafti M, Shahesmaeili A. Opium and cigarette smoking are independently associated with bladder cancer: the findings of a matched case - control study. Asian Pac J Cancer Prev. 2021;22(10):3385–91.
pubmed: 34711016
pmcid: 8858234
doi: 10.31557/APJCP.2021.22.10.3385
Akbari M, Naghibzadeh-Tahami A, Khanjani N, Baneshi MR, Kamali E, Hesampour M, et al. Opium as a risk factor for bladder cancer: a population-based case-control study in Iran. Arch Iran Med. 2015;18(9):567–71.
pubmed: 26317596
Alizadeh H, Naghibzadeh Tahami A, Khanjani N, Yazdi-Feyzabadi V, Eslami H, Borhaninejad V, et al. Opium use and head and neck cancers: a matched case-control study in Iran. Asian Pac J Cancer Prev. 2020;21(3):783–90.
pubmed: 32212808
pmcid: 7437338
doi: 10.31557/APJCP.2020.21.3.783
Masjedi MR, Naghan PA, Taslimi S, Yousefifard M, Ebrahimi SM, Khosravi A, et al. Opium could be considered an independent risk factor for lung cancer: a case-control study. Respir Int Rev Thorac Dis. 2013;85(2):112–8.
Naghibzadeh-Tahami A, Marzban M, Yazdi-Feyzabadi V, Dabiri S, Mohseni S, Abbasi Rayeni R, et al. Is opium use associated with an increased risk of lung cancer? A case-control study. BMC Cancer. 2020;20(1):807.
pubmed: 32842991
pmcid: 7448970
doi: 10.1186/s12885-020-07296-0
Naghibzadeh-Tahami A, Marzban M, Yazdi-Feyzabadi V, Khazaei Z, Zahedi MJ, Moazed V, et al. Opium use as an independent risk factor for pancreatic cancer: a case-control study. Cancer Epidemiol. 2021;75:102017.
pubmed: 34626910
doi: 10.1016/j.canep.2021.102017
Shakeri R, Kamangar F, Mohamadnejad M, Tabrizi R, Zamani F, Mohamadkhani A, et al. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Medicine (Baltimore). 2016;95(28):e3922.
pubmed: 27428185
doi: 10.1097/MD.0000000000003922
Naghibzadeh Tahami A, Khanjani N, Yazdi Feyzabadi V, Varzandeh M, Haghdoost AA. Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran. Arch Iran Med. 2014;17(1):2–6.
pubmed: 24444058
Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. Int J Epidemiol. 2022;51(3):830–838.
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–60.
pubmed: 31563865
doi: 10.1136/ebmental-2019-300117
R Development Core Team. R Development Core Team. R: A language and environment for statistical computing [computer programme]. Vienna, Austria: R Foundation for Statistical Computing; 2014.
Shakeri R, Kamangar F, Nasrollahzadeh D, Nouraie M, Khademi H, Etemadi A, et al. Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PLoS ONE. 2012;7(3):e32711.
pubmed: 22396792
pmcid: 3291619
doi: 10.1371/journal.pone.0032711
Rashidian H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, Marzban M, Mohebbi E, et al. Opium use and risk of lung cancer: a multicenter case-control study in Iran. Int J Canc. 2023;152(2):203–213.
pubmed: 36043555
doi: 10.1002/ijc.34244
Rashidian H, Haghdoost AA, Hadji M, Marzban M, Gholipour M, Zendehdel K. Association between opium use and bladder cancer: a case-control study in a high risk area of Iran. Clin Epidemiol Glob Health. 2021;11:100772.
doi: 10.1016/j.cegh.2021.100772
Momayez Sanat Z, Masoudi S, Mansouri M, Ghamarzad Shishavan N, Jameshorani M, Pourshams A. Diabetes mellitus, obesity, and risk of pancreatic ductal adenocarcinoma: a large case-control study from Iran. Middle East J Dig Dis. 2021;13(1):15–20.
pubmed: 34712433
pmcid: 8531941
doi: 10.34172/mejdd.2021.198
Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev. 2004;13(6):1068–70.
pubmed: 15184266
doi: 10.1158/1055-9965.1068.13.6
Ghadimi T, Gheitasi B, Nili S, Karimi M, Ghaderi E. Occupation, smoking, opium, and bladder cancer: a case-control study. South Asian J Cancer. 2015;4(3):111–4.
pubmed: 26942139
pmcid: 4756483
doi: 10.4103/2278-330X.173174
Hosseini SY, Safarinejad MR, Amini E, Hooshyar H. Opium consumption and risk of bladder cancer: a case-control analysis. Urol Oncol. 2010;28(6):610–6.
pubmed: 19110453
doi: 10.1016/j.urolonc.2008.10.016
Ketabchi A, Gharaei M, Ahmadinejad M, Meershekari T. Evaluation of bladder cancer in opium addicted patients in the Kerman province, Iran from 1999 to 2003. J Res Med Sci. 2005;10(6):355–7.
Lotfi MH, Farzaneh F, Mehrparvar AH, Fallahzadeh MH, Sadeghian MR. The effect of smoking and opium on bladder cancer in Yazd province: a case–control study. SSU. 2016;5:98–109.
Shakhssalim N, Hosseini SY, Basiri A, Eshrati B, Mazaheri M, Soleimanirahbar A. Prominent bladder cancer risk factors in Iran. Asian Pac J Cancer Prev. 2010;11(3):601–6.
pubmed: 21039023
Berjis N, Rogha M, Shahabeddini M. The relationship between the opium drug and the risk of laryngeal squamous cell cancer. Ambient Sci. 5 Suppl 1:16–9. https://doi.org/10.21276/ambi.2018.05.sp1.ta01
doi: 10.21276/ambi.2018.05.sp1.ta01
Mohebbi E, Hadji M, Rashidian H, Rezaianzadeh A, Marzban M, Haghdoost AA, et al. Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 2021;148(5):1066–76.
pubmed: 32895947
doi: 10.1002/ijc.33289
Mousavi MRA, Damghani MA, Haghdoust AA, Khamesipour A. Opium and risk of laryngeal cancer. Laryngoscope. 2003;113(11):1939–43.
pubmed: 14603052
doi: 10.1097/00005537-200311000-00016
Karajibani M, Montazerifar F, Dashipour A, et al. Nutritional risk factors in the gastric cancer patients attending in Imam Ali Hospital, Zahedan, Iran. RMJ. 2014;39:19–24.
Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al. Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer. 2013;133(2):455–61.
pubmed: 23319416
doi: 10.1002/ijc.28018
IARC. Tobacco smoke and involuntary smoking. IARC Monogr Identif Carcinog Hazards Hum. 2004;83:1–1438 (Internet).
IARC (2012). Personal habits and indoor combustions. IARC Monogr Eval Carcinog Risks Hum, 100E:1–575. [Internet]. Place of publication not identified: International Agency for Research on Cancer; 2012 [cited 2022 May 11]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304391
IARC. Drinking coffee, mate, and very hot beverages. IARC Monogr Eval Carcinog Risks Hum. 2018;116:1–499 (Internet).
IARC (1994). Schistosomes, liver flukes, and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum, 61:1–270. [Internet]. Lyon; 1994. 270 p. (IARC monographs on the evaluation of carcinogenic risks to humans). Available from: https://www.ncbi.nlm.nih.gov/books/NBK304391
Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al. (2012) Opium use and mortality in Golestan cohort study: prospective cohort study of 50,000 adults in Iran. BMJ. 2012;344(apr 17 2):e2502.
pubmed: 22511302
pmcid: 3328545
doi: 10.1136/bmj.e2502
Mohebbi E, Kamangar F, Rahimi-Movaghar A, Haghdoost AA, Etemadi A, Amirzadeh S, et al. An exploratory study of units of reporting opium usein Iran: implications for epidemiologic studies. Arch Iran Med. 2019;22(10):541–5.
pubmed: 31679354
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.
pubmed: 18436948
pmcid: 2335261
doi: 10.1136/bmj.39489.470347.AD
Steenland K, Schubauer-Berigan MK, Vermeulen R, Lunn RM, Straif K, Zahm S, et al. Risk of bias assessments and evidence syntheses for observational epidemiologic studies of environmental and occupational exposures: strengths and limitations. Environ Health Perspect. 2020;128(9):095002.
pubmed: 32924579
pmcid: 7489341
doi: 10.1289/EHP6980
Schubauer-Berigan MK, Richardson DB, Fox MP, Fritschi L, Guseva Canu I, Pearce N, Stayner LT, Berrington de Gonzalez A. IARC-NCI Workshop on an epidemiological toolkit to assess biases in human cancer studies for hazard identification: beyond the algorithm. Occup Environ Med. 2023 Jan 30:108724.
Lim H-Y, Kwok S-F. Differentiation and comparison of raw, prepared and dross opium. Vienna: United Nations Office on Drugs and Crime; 1981.
Labanca F, Ovesnà J, Milella L. Papaver somniferum L. taxonomy, uses and new insight in poppy alkaloid pathways. Phytochem Rev. 2018;17(4):853–71.
doi: 10.1007/s11101-018-9563-3
Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103(24):1827–39.
pubmed: 22158127
pmcid: 3243677
doi: 10.1093/jnci/djr483
Etemadi A, Poustchi H, Calafat AM, Blount BC, De Jesús VR, Wang L, et al. Opiate and tobacco use and exposure to carcinogens and toxicants in the Golestan cohort study. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2020;29(3):650–8.
doi: 10.1158/1055-9965.EPI-19-1212
Perry PE, Thomson EJ, Vijayalaxmi, Evans HJ, Day NE, Bartsch H. Induction of SCE by opium pyrolysates in CHO cells and human peripheral blood lymphocytes. Carcinogenesis. 1983;4(2):227–30.
pubmed: 6825211
doi: 10.1093/carcin/4.2.227
Abedi-Ardekani B, Kamangar F, Sotoudeh M, Villar S, Islami F, Aghcheli K, et al. Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, Iran. PLoS ONE. 2011;6(12): e29488.
pubmed: 22216294
pmcid: 3246475
doi: 10.1371/journal.pone.0029488
Moody S, Senkin S, Islam SMA, Wang J, Nasrollahzadeh D, Cortez Cardoso Penha R, et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 2021;53(11):1553–63.
pubmed: 34663923
doi: 10.1038/s41588-021-00928-6
Warnakulasuriya S, Cronin-Fenton D, Jinot J, Kamangar F, Malekzadeh R, Dar NA, et al. Carcinogenicity of opium consumption. Lancet Oncol. 2020;21(11):1407–8.
doi: 10.1016/S1470-2045(20)30611-2